BATS BZX Real-Time Price
As of Mar 15
| 0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for Nabriva Therapeutics PLC have a median target of 1.00, with a high estimate of 1.00 and a low estimate of 1.00. The median estimate represents a -33.33% decrease from the last price of 1.50.
The current consensus among 2 polled investment analysts is to Hold stock in Nabriva Therapeutics PLC. This rating has held steady since January, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.